Article

Acquisitions Turn Buyers Into Users of Their Own Targets

Across this week's deals, OpenAI, AMD and Oura are all acquiring capabilities they intend to put to work inside their own operations or products, not just resell.

ManishankarNovember 16, 20264 min read

The acquisitions logged on this beat this week share one thread: the buyers are not shopping for revenue or market share so much as for a capability they intend to consume themselves. OpenAI, AMD and Oura are each putting a newly acquired asset to work inside their own operations or products. That makes these deals closer to infrastructure decisions than to conventional M&A, and it changes what US technology companies, their investors and their customers should be looking at when such a deal is announced.

Buying A Capability, Not A Business

In a classic acquisition, the acquirer buys a company, folds it in and keeps selling what it sold. The stories here point somewhere else. As Tom's Hardware reported, AMD has revealed that its own IT infrastructure is running servers at 50 percent DRAM capacity while achieving 95 percent of the performance of a full-DRAM system in certain applications, using technology from MEXT, which AMD acquired earlier this year. The buyer is the first customer. Oura's acquisition of Counsel Health, as ZDNET reported, could signal a new dawn for digital care, with the suggestion that Oura Ring users may soon get in-app access to real doctors. Again, the asset is meant to show up inside the product rather than beside it. OpenAI's acquisition of Odessia, the travel startup created by Sonder founder Francis Davidson, fits the same mold, though less visibly: TechCrunch reported that OpenAI has not yet said what its plans are for the future of travel. The buyer has purchased an option on a capability it has not yet chosen to exercise.

What The Buyers Actually Bought

The three targets have almost nothing in common on paper. Odessia is a travel startup. MEXT is a technology AMD is using to stretch memory. Counsel Health is described as the basis for in-app access to real doctors. What unites them is that each fills a gap the acquirer would otherwise have to build, license or buy at market rates, and each gap sits close to the buyer's core product. For AMD, the constraint is memory, and the acquired technology is already proving itself on AMD's own servers, per Tom's Hardware. For Oura, the gap is clinical credibility and human care behind a wearable, and Counsel Health supplies it, per ZDNET. For OpenAI, the gap is less defined, and the company has said nothing about its plans, according to TechCrunch. The pattern is not about which sectors are hot. It is about where the buyer's own bottleneck sits.

The Integrate-It-Yourself Doctrine

What distinguishes this crop of deals is the expectation of integration rather than resale. AMD is not positioning MEXT as a product line to be sold on its own; the demonstration is that AMD's own infrastructure benefits. Oura is not buying a clinic to run as a separate business; the acquisition is framed around what ring users may see in the app. This is a demanding form of acquisition. It requires the buyer to have the engineering and operational capacity to absorb the target, and it puts the target's technology on the buyer's own balance sheet as a cost center before it ever becomes a revenue line. For US technology companies weighing similar moves, the implication is that the diligence question shifts from "what will this earn?" to "what will this save or unlock inside our existing stack?" That is a harder case to make to a board, and an easier one to test in production.

Why US Buyers Are Leaning This Way

The appeal for US technology companies is straightforward. When a capability is scarce or expensive in the open market, owning it converts an ongoing cost into a fixed one. AMD's memory work is the clearest illustration: the company has shown it can hold performance at half the DRAM capacity in certain applications, as Tom's Hardware reported. Whether or not that translates into relief from broader memory shortages, it shows a buyer treating an acquisition as a way to reduce exposure to a constrained input. Oura's move points at a different scarcity, that of clinician attention and trust, which is difficult to license at scale but possible to own. In both cases the acquisition is a hedge against dependence on suppliers or partners the buyer cannot control. The OpenAI case is the least legible, precisely because the company has not said what it intends, per TechCrunch.

What It Means For The US Market

For the US market, the near-term effect is that acquisitions of this kind are harder to read as signals of demand. A deal no longer tells you which market the buyer intends to enter; it tells you which constraint the buyer is trying to relieve. That makes some announcements less informative than they look. It also raises a question about competition. If the value of a target lies in being absorbed rather than operated independently, smaller companies with useful technology may find fewer buyers willing to let them stand alone. US consumers, meanwhile, are likely to encounter these deals as features rather than as brands: a wearable that connects to a doctor, servers that need less memory, a travel capability that may or may not surface in a product. The acquisition disappears into the experience, which is arguably the point.

What To Watch

The clearest thing to watch is disclosure. AMD has already shown its hand by describing how MEXT performs on its own infrastructure, per Tom's Hardware. Oura's plans depend on whether in-app access to real doctors actually arrives for ring users, which ZDNET framed as a possibility rather than a shipped feature. OpenAI is the open question: TechCrunch reported that the company has not yet said what its plans are for the future of travel, and until it does, the Odessia deal is a capability held in reserve. Watch whether these buyers describe their acquisitions as things they use or things they sell. On this beat, that distinction is becoming the story.

More on this beat: Companies on TechManNews.

#acquisitions#OpenAI#AMD#Oura#M&A strategy#US technology

Newsletter

Get Tech News in Your Inbox

The latest AI, gadgets, software and startup stories from TechManNews, delivered every morning - free.